Sundeep Mani Shukla, MD | |
115 W Silver St, Westfield, MA 01085-3678 | |
(413) 568-2811 | |
Not Available |
Full Name | Sundeep Mani Shukla |
---|---|
Gender | Male |
Speciality | Emergency Medicine |
Experience | 19 Years |
Location | 115 W Silver St, Westfield, Massachusetts |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1134361165 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207P00000X | Emergency Medicine | 258050 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Baystate Noble Hospital | Westfield, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Baystate Medical Practices Inc | 5991602971 | 1015 |
News Archive
A new study finds that most older long-term cancer survivors who are interested in diet and exercise actually have poor health habits.
Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA).
Focal malformations of cortical development are a heterogeneous group of brain cortical abnormalities.
Combating losses due to patent expiries has become a high priority for pharmaceutical companies. Investing in new drug delivery technologies is becoming a critical strategy for them to maintain a strong presence in this cut-throat market as they offer the potential to enhance the life cycle of established drugs.
A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia, one of the most common forms of blood cancer.
› Verified 8 days ago
Entity Name | Baystate Medical Practices Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548205909 PECOS PAC ID: 5991602971 Enrollment ID: O20040225000080 |
News Archive
A new study finds that most older long-term cancer survivors who are interested in diet and exercise actually have poor health habits.
Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA).
Focal malformations of cortical development are a heterogeneous group of brain cortical abnormalities.
Combating losses due to patent expiries has become a high priority for pharmaceutical companies. Investing in new drug delivery technologies is becoming a critical strategy for them to maintain a strong presence in this cut-throat market as they offer the potential to enhance the life cycle of established drugs.
A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia, one of the most common forms of blood cancer.
› Verified 8 days ago
Entity Name | Baystate Wing Hospital Corporation |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1962410233 PECOS PAC ID: 9335048321 Enrollment ID: O20040511000400 |
News Archive
A new study finds that most older long-term cancer survivors who are interested in diet and exercise actually have poor health habits.
Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA).
Focal malformations of cortical development are a heterogeneous group of brain cortical abnormalities.
Combating losses due to patent expiries has become a high priority for pharmaceutical companies. Investing in new drug delivery technologies is becoming a critical strategy for them to maintain a strong presence in this cut-throat market as they offer the potential to enhance the life cycle of established drugs.
A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia, one of the most common forms of blood cancer.
› Verified 8 days ago
Entity Name | Baystate Franklin Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1508867391 PECOS PAC ID: 9638151731 Enrollment ID: O20040602001590 |
News Archive
A new study finds that most older long-term cancer survivors who are interested in diet and exercise actually have poor health habits.
Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA).
Focal malformations of cortical development are a heterogeneous group of brain cortical abnormalities.
Combating losses due to patent expiries has become a high priority for pharmaceutical companies. Investing in new drug delivery technologies is becoming a critical strategy for them to maintain a strong presence in this cut-throat market as they offer the potential to enhance the life cycle of established drugs.
A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia, one of the most common forms of blood cancer.
› Verified 8 days ago
Entity Name | Westfield Emergency Physicians, P.c. |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1902852205 PECOS PAC ID: 8921084146 Enrollment ID: O20040628001405 |
News Archive
A new study finds that most older long-term cancer survivors who are interested in diet and exercise actually have poor health habits.
Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA).
Focal malformations of cortical development are a heterogeneous group of brain cortical abnormalities.
Combating losses due to patent expiries has become a high priority for pharmaceutical companies. Investing in new drug delivery technologies is becoming a critical strategy for them to maintain a strong presence in this cut-throat market as they offer the potential to enhance the life cycle of established drugs.
A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia, one of the most common forms of blood cancer.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Sundeep Mani Shukla, MD 280 Chestnut St, 2nd Floor, Springfield, MA 01199-1619 Ph: (413) 794-5700 | Sundeep Mani Shukla, MD 115 W Silver St, Westfield, MA 01085-3678 Ph: (413) 568-2811 |
News Archive
A new study finds that most older long-term cancer survivors who are interested in diet and exercise actually have poor health habits.
Bayer HealthCare announced today that new data on the oncology portfolio, including Nexavar (sorafenib) tablets, Stivarga (regorafenib) tablets and the recently U.S. Food and Drug Administration approved product Xofigo (radium Ra 223 dichloride) injection will be presented at the 49th Annual Meeting of the American Society of Clinical Oncology, May 31 – June 4, in Chicago, IL (USA).
Focal malformations of cortical development are a heterogeneous group of brain cortical abnormalities.
Combating losses due to patent expiries has become a high priority for pharmaceutical companies. Investing in new drug delivery technologies is becoming a critical strategy for them to maintain a strong presence in this cut-throat market as they offer the potential to enhance the life cycle of established drugs.
A common and inexpensive drug may be used to counteract treatment resistance in patients with acute myeloid leukemia, one of the most common forms of blood cancer.
› Verified 8 days ago
Dr. Matthew Gray, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 W Silver St, Westfield, MA 01085 Phone: 413-568-2811 | |
Brian Paul Sutton, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 W Silver St, Westfield, MA 01085 Phone: 413-568-2811 | |
Jonathan J Pickos, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 115 W Silver St, Westfield, MA 01085 Phone: 413-568-2811 | |
Stuart R. Rose, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 115 W Silver St, Westfield, MA 01085 Phone: 413-568-2811 Fax: 610-834-2862 | |
Stanley D. Strzempko, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 115 W Silver St, Westfield, MA 01085 Phone: 413-568-2811 Fax: 610-834-2862 | |
Dr. Eileen A. Whalen, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 57 Union St, Ste 101, Westfield, MA 01085 Phone: 413-642-7200 Fax: 413-562-1821 |